Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving hundreds of leading biopharmaceutical companies globally:

Teva
Healthtrust
Chubb
Farmers Insurance
US Army
Deloitte
Colorcon
AstraZeneca
Accenture

Generated: April 24, 2018

DrugPatentWatch Database Preview

Details for New Drug Application (NDA): 019415

« Back to Dashboard

NDA 019415 describes FERTINEX, which is a drug marketed by Serono and is included in one NDA. Additional details are available on the FERTINEX profile page.

The generic ingredient in FERTINEX is urofollitropin. There is one drug master file entry for this compound. One supplier is listed for this compound. Additional details are available on the urofollitropin profile page.
Summary for 019415
Tradename:FERTINEX
Applicant:Serono
Ingredient:urofollitropin
Patents:0
Formulation / Manufacturing:see details

Profile for product number 002

Active Rx/OTC/Discontinued:DISCNDosage:INJECTABLE;INTRAMUSCULARStrength75 IU/AMP
Approval Date:Sep 18, 1986TE:RLD:No

Profile for product number 003

Active Rx/OTC/Discontinued:DISCNDosage:INJECTABLE;INTRAMUSCULARStrength150 IU/AMP
Approval Date:Sep 18, 1986TE:RLD:No

Profile for product number 004

Active Rx/OTC/Discontinued:DISCNDosage:INJECTABLE;SUBCUTANEOUSStrength150 IU/AMP
Approval Date:Aug 23, 1996TE:RLD:No

Expired US Patents for NDA 019415

Applicant Tradename Generic Name Dosage NDA Approval Date Patent No. Patent Expiration
Serono FERTINEX urofollitropin INJECTABLE;SUBCUTANEOUS 019415-004 Aug 23, 1996 ➤ Sign Up ➤ Sign Up
Serono FERTINEX urofollitropin INJECTABLE;SUBCUTANEOUS 019415-005 Aug 23, 1996 ➤ Sign Up ➤ Sign Up
Serono FERTINEX urofollitropin INJECTABLE;SUBCUTANEOUS 019415-005 Aug 23, 1996 ➤ Sign Up ➤ Sign Up
Serono FERTINEX urofollitropin INJECTABLE;SUBCUTANEOUS 019415-005 Aug 23, 1996 ➤ Sign Up ➤ Sign Up
Applicant Tradename Generic Name Dosage NDA Approval Date Patent No. Patent Expiration

This preview shows a limited data set. Subscribe for full access, or try a Free Trial

Complete Access Available with Subscription

For more information try a trial or see the plans and pricing

Serving hundreds of leading biopharmaceutical companies globally:

Citi
Johnson and Johnson
Mallinckrodt
QuintilesIMS
Teva
Express Scripts
Healthtrust
Cantor Fitzgerald
Accenture

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.